INC Research - Clinical Trials in CNS and Oncology

For over two decades, INC Research has been providing therapeutically focused drug development services to pharmaceutical and biotech customers around the globe. As a specialized Contract Research Organization (CRO) we're fully dedicated to managing programs for companies developing drugs in the complex areas of neurology, psychiatry, pain and cancer research. We also offer specialized pediatric drug development expertise and a full range of data management services across all therapeutic areas.

Our team comprises the brightest people in the industry with years of Central Nervous System (CNS), oncology, data management and industry-related experience.

CNS EXPERTISE

At INC Research, we are recognized as leaders in the field of CNS research. For over 20 years, we've conducted trials in pain, neurology and psychiatry. The strength of our team's first-hand knowledge in the areas of psychiatry, neurology and pain is brought directly to bear on our customers' critical CNS drug development programs.

As a niche provider, INC CNS has conducted 200 global CNS trials involving over 43,600 adult and pediatric patients at over 3,100 sites in 26 countries.

PAIN TRIALS AND RESEARCH SERVICES

Our team of experienced pain experts has the requisite scientific and clinical research experience to successfully run pain trials based on the differing pain models.

Key areas of our clinical expertise in pain include: arthritis; bunionectomy; cancer pain; chronic low back; dental / TMJ; diabetic neuropathy; fibromyalgia; headache; migraine; musculoskeletal pain; peripheral neuropathy; post-herpetic neuralgia; and post operative pain.

NEUROLOGY TRIALS AND RESEARCH SERVICES

We understand the particular complexities involved when undertaking a trial for a treatment for Parkinson's disease versus Alzheimer's disease, or the different requirements for planning and implementing an in-patient stroke versus an out-patient multiple sclerosis trial. We have in-house scientific, medical, regulatory, monitoring, project management and data expertise - all in CNS - to provide whatever level of support is needed to run clinical programs for the breadth of neurological disorders.

We have longstanding relationships with a global network of neurologists who have access to large CNS patient populations. Our ability to access this exceptional, experienced pool of CNS specialists helps us to accelerate patient recruitment and significantly condense enrollment timelines.

PSYCHIATRY TRIALS AND RESEARCH SERVICES

At INC Research, we are familiar with the unique challenges associated with successful conduct of clinical trials for psychiatric disorders. To begin with, the diagnosis of mental disorders is difficult in itself; qualifying the appropriate patients for inclusion in a psychiatric drug trial takes skilled, experienced clinicians. The diagnosis is based on subjective criteria - patients' reports of the intensity and duration of symptoms, signs from their mental status examination and physicians' observation of their behavior. We have access to leading academic and private practice investigative sites, whose specialty is evaluating, diagnosing and treating the psychiatric patient populations clients seek.

ONCOLOGY EXPERTISE

INC Oncology has the experience and resources to help clients with any facet of research, whether it's prevention, detection or diagnosis, treatment, palliative and supportive care or survivorship / outcomes.

Our dedicated oncology team offers a depth of clinical expertise from early stage planning, study design and management through all phases of cancer trials. In addition to our clinical experience, we have provided regulatory planning and consulting, statistical analysis advice and medical writing support on numerous oncology programs.

PATIENT ACCRUAL IN CANCER TRIALS

At INC Oncology we understand the unique challenges associated with patient accrual in cancer trials. Our team of seasoned oncology professionals has generated long-standing relationships with key oncology thought leaders, investigators (both academic and community based), professional societies, cancer cooperative groups and patient support groups.

Our experienced staff is spread strategically through all key countries, with critical knowledge of regional nuances. Thus, we can access large numbers of appropriate patients in areas such as Central and Eastern Europe. In addition, our team utilizes a variety of proactive recruitment methods to speed enrollment across all trials.

With a presence in 32 countries worldwide, we can deploy our therapeutically specialized services anywhere, on any scale.